Skip to content
Screener

LeMaitre Vascular LMAT US — Revenue (Gross)

Other geography segments

DE
$4.46M—
CA
$3.96M—
GB
$3.3M—

Similar metrics at other companies

G-III Apparel Group logo
GIIIUS — Revenue (Gross)
$571.22M-7.2%
IDT Corporation logo
IDTUS — Revenue (Gross)
$251.27M+5.2%
Quantum Computing Inc. logo
QUBTUS — Revenue (Gross)
$148K+58.7%
JHG
JHGUS — Revenue (Gross)
$534.45M+35.1%
OSI Systems logo
OSISUS — Revenue (Gross)
$140.76M+6.8%
RF Industries logo
RFILUS — Revenue (Gross)
$19.03M+15.6%

Other financials

Income statement

See full
Revenue$70.4M+9.6%
Gross profit$50.8M+12.9%
Operating income$20.4M+26.4%
Net income$17.1M+23.7%
EPS (diluted)$0.74+23.3%

Balance sheet

See full
Cash & equivalents$26.6M-2.0%
Total debt$21.2M+19.7%
Total equity$420.3M+15.9%
Total assets$640.5M+10.9%

Cash flow

See full
Operating cash flow$16.0M-21.3%
CapEx$2.3M+72.4%
Free cash flow$13.7M-28.0%

Valuation

See full
Market cap$1.85B-12.4%
Enterprise value$1.84B-12.3%
P/E28.1×-16.6×
P/S7×-2.0×

Profitability

See full
Gross margin72.9%+3.8pp
Operating margin29.5%+6.1pp
Net margin25%+4.9pp
FCF margin28.1%+5.8pp

Returns & leverage

See full
Return on equity16.8%+3.0pp
Debt / equity0.1×0.0×
Current ratio16.3×+2.4×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 6:30 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333762
Line itemThree months ended / June 30, 2026Three months ended / June 30, 2025Six months ended / June 30, 2026Six months ended / June 30, 2025
Net sales$70,382$64,232$136,933$124,103
Cost of sales19,61819,25837,77337,709
Gross profit50,76444,97499,16086,394
Sales and marketing14,40814,89528,92329,107
General and administrative11,11010,39623,15620,883
Research and development4,8473,5418,9077,636
Total operating expenses30,36528,83260,98657,626
Income from operations20,39916,14238,17428,768

Item 1. Financial Statements

FAQ

What is LeMaitre Vascular's US — revenue (gross)?
LeMaitre Vascular (LMAT) reported US — revenue (gross) of $38.25M in Q2 2026.
How has LeMaitre Vascular's US — revenue (gross) changed year-over-year?
LeMaitre Vascular's US — revenue (gross) increased by 4.3% year-over-year, from $36.66M to $38.25M.
What is the long-term trend for LeMaitre Vascular's US — revenue (gross)?
Over 4 years (2021 to 2025), LeMaitre Vascular's US — revenue (gross) has grown at a 10.8% compound annual growth rate (CAGR), from $93.87M to $141.57M.
What does US — revenue (gross) mean?
This metric represents the total gross revenue generated from sales of medical devices within the United States geographic segment, inclusive of any assessed taxes. It serves as a primary indicator of market penetration and demand for the company's vascular surgical products in its domestic market.

Ask your AI about LeMaitre Vascular's us — revenue (gross).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude